- Autobacs Seven is evaluating EV sales in Japan through a multinational joint venture initiative.
- The JV includes Chery Automobile and other partners focused on EV development and sales systems.
Autobacs Seven is aiming to enter the electric vehicle market in Japan by 2027 through a joint venture formed with multiple Japanese and Chinese companies, according to recently revealed information. The initiative is being led by Electric Mobility Technology Pte. Ltd. (EMT), a Singapore-based joint venture entity, with its subsidiary EMT Co., Ltd. headquartered in Yokohama taking responsibility for studying vehicle development and establishing future sales systems. The project reflects growing collaboration between automotive and technology-related firms seeking to expand EV adoption across the Japanese market.
The joint venture involves participation from several companies across Asia, including Chery Automobile from China. Additional investors include Jiangsu Yueda Kia Motor, battery manufacturer Gotion High-tech, and paint equipment company Anest Iwata. The structure of the collaboration highlights the increasing trend of cross-border partnerships in the EV sector, where automotive manufacturing, battery technology, and supporting industrial expertise are being combined to strengthen product development and commercialization capabilities.
According to the disclosed details, EMT Co., Ltd. is currently evaluating multiple operational areas related to the proposed EV business. These studies include vehicle development activities, sales channel preparation, and overall commercialization strategies intended for the Japanese market. The project is expected to leverage expertise from both Japanese and Chinese partners as companies continue responding to rising electrification demand and evolving mobility trends throughout the automotive industry.
On May 11, Autobacs Seven confirmed that it had invested in the Singapore-based joint venture. However, the company clarified that it had not officially announced plans regarding electric vehicle sales in Japan. The statement indicates that while investment participation has been acknowledged, further details surrounding vehicle lineup plans, launch schedules, or commercial strategies remain under evaluation as the joint venture continues its development activities.
Frequently Asked Questions
What is the purpose of the Autobacs Seven joint venture?
The joint venture aims to study and potentially develop electric vehicle sales operations for the Japanese market by 2027. The collaboration brings together Japanese and Chinese companies with expertise in automotive manufacturing, batteries, and industrial technologies. EMT Co., Ltd., a subsidiary of the Singapore-based Electric Mobility Technology Pte. Ltd., is leading vehicle development and sales system studies. Although Autobacs Seven confirmed its investment in the venture, the company stated that it has not officially announced EV sales plans in Japan at this stage.
Which companies are participating in the EV joint venture?
The joint venture includes Autobacs Seven, Chery Automobile, Jiangsu Yueda Kia Motor, Gotion High-tech, and Anest Iwata, along with other partners. The initiative combines expertise from automotive production, battery manufacturing, and industrial equipment sectors to support EV business development. The collaboration reflects a broader industry trend of multinational partnerships focused on accelerating electrification projects and preparing future mobility solutions for regional automotive markets, particularly in Japan and other Asian markets.
Click above to visit the official source.